Discovery projects

Overview

Gut microbiome-based innovations are still in their infancy and hold vast potential. Our drug discovery projects target life-impacting diseases for which there are few or no existing treatments.

Microbiome-related R&D activities in the academic world are growing rapidly, especially in high-potential therapeutic fields (such as inflammatory diseases, cancer and neurodegenerative diseases).

Using our expertise and understanding of the microbiome, we are constantly looking for detecting new innovation and projects that have the potential to become innovative microbiome-based drug candidates.

We welcome understanding research teams working on the microbiome to engage with us.

Want to talk to our CSO?

LNC02
program

LNC02 is a technical platform dedicated to developing expert know-how on Christensenella.

For this purpose, LNC is setting up a technical platform dedicated to studying the bacteria’s mechanisms of action, isolating new bacterial strains and targeting new therapeutic applications.

Microbiome & us
News
Nov 5, 2019
LNC Therapeutics Announces Formation of its Scientific Advisory Board | Appoints international experts with...
> more
Oct 22, 2019
LNC Therapeutics chooses Luina Bio for the development and GMP manufacturing of its first live bio therapeutic product...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Publications
Jan 11, 2019
Comparison of the Gut Microbiota of Centenarians in Longevity Villages of South Korea with Those of Other Age Groups...
> more
Jan 2, 2019
Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders   Marialetizia...
> more
now on twitter
LNC Therapeutics

A new study indicates that poor sleep can negatively affect your gut microbiome, which can, in turn, lead to additi… t.co/ecLUwm0wLs

LNC Therapeutics © 2019 - all rights reserved terms and conditions